Lancet Respiratory Medicine

杂志介绍

Lancet Respiratory Medicine杂志介绍

《Lancet Respiratory Medicine》是一本以English为主的未开放获取国际优秀期刊，中文名称柳叶刀呼吸内科，本刊主要出版、报道医学-CRITICAL CARE MEDICINE领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为38.7，最新CiteScore 指数为87.1。

本刊近期中国学者发表的论文主要有：

• Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study

  Author: Solomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta

• Rising smoking epidemic among adolescents in China

  Author: Dan Xiao, Chen Wang

• Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study

  Author: Shuo Feng, Susan S Chiu, Eunice L Y Chan, Mike Y W Kwan, Joshua S C Wong, Chi-Wai Leung, Yiu Chung Lau, Sheena G Sullivan, J S Malik Peiris, Benjamin J Cowling

• Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013

  Author: Minghuan Wang, Xiang Luo, Shabei Xu, Wenhua Liu, Fengfei Ding, Xiaoxiang Zhang, Liang Wang, Jian Liu, Jianping Hu, Wei Wang

英文介绍

Lancet Respiratory Medicine杂志英文介绍

The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.

The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.

Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript.

Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.

To find out more about The Lancet Respiratory Medicine, visit www.thelancet.com/respiratory.